Skip to main content
PLOS One logoLink to PLOS One
. 2026 May 11;21(5):e0344330. doi: 10.1371/journal.pone.0344330

Psychological well-being of SLE patients: A comprehensive examination of stress, depression, anxiety and quality of life

Pragya Singhal 1, Priyanka Srivastava 1,*, Liza Rajasekhar 2
Editor: Aditya K Panda3
PMCID: PMC13160299  PMID: 42113820

Abstract

Systemic Lupus Erythematosus (SLE/Lupus) is a chronic autoimmune disease affecting various organs, and associated with challenges in emotion and mood regulation. Despite the increasing prevalence of SLE globally and in India, neuropsychological data remain underrepresented. This study investigates the psychological health and quality of life among Indian SLE patients using self-reported questionnaires on depression, generalized anxiety, trait anxiety, stress, and quality of life. Results indicate a high prevalence of stress, depression, and both generalized and trait anxiety among the SLE patients. Additionally, SLE patients exhibited significantly reduced quality of life (physical well-being, social relationships, and environmental conditions) compared to their healthy counterparts. Disease severity was significantly correlated with patients’ psychological health and quality of life, highlighting the substantial impact of the disease on individual well-being and their daily functioning. Further, cluster analysis revealed that older SLE patients with a homemaker background reported poorer psychological well-being compared with younger patients with a student background, highlighting the importance of demographic factors in understanding the SLE heterogeneity. In sum, poorer psychological well-being across demographic groups underscores the need for future research examining ethnic diversity within India and for translating these findings into holistic medical plans aimed at improving patients’ quality of life.

Introduction

Systemic Lupus Erythematosus (SLE) stands as a multifaceted autoimmune disease known for its diverse clinical manifestations, impacting mainly women and specific ethnic groups such as African or Asian populations [1]. Its dynamic nature yields a variable disease trajectory, necessitating continual monitoring to spot emerging or recurrent organ and systemic involvements. The complexity of SLE lies in its heterogeneous presentation and the uncertain course it takes, making it a challenging disorder to diagnose and manage [2]. It is marked by a spectrum of shared symptoms like rashes across the cheeks and nose, anaemia, debilitating fatigue, hair loss, joint inflammation and swelling, susceptibility to blood clotting, and recurring headaches. The distinctiveness of SLE resides not only in its clinical diversity but also in its ability to impact other organs in the body, including the central nervous system (brain and spinal cord), adding complexity to diagnosis and treatment strategies.

The American College of Rheumatology (ACR) nomenclature system acknowledges the manifestation of neuropsychiatric disorders in SLE disease. Although the prevalence of reported neuropsychiatric syndromes of systemic lupus erythematosus (NPSLE) varies from 6% to 91% [3], the most commonly reported disorders are acute confused state, anxiety, mood and psychosis, and emotion and mood regulation [46]. In a recent study, 68% of SLE patients (n = 176) reported symptoms of depression, and 57.4% reported anxiety [7]. Notably, the reported psychological distress was observed in SLE patients even in the absence of apparent neuropsychiatric symptoms (non-NPSLE) [8]. When compared with patients with rheumatoid arthritis (another autoimmune disease), patients with SLE reported comparatively higher level of distress [8]. In sum, the high prevalence of depression and anxiety in SLE disease, regardless of overt neuropsychiatric symptoms, emphasizes the heterogeneous nature of the NPSLE and impedes the timely diagnosis. Further, the prevalence of psychological symptoms among healthy young adults [9,10] interferes with the attribution of psychological health challenges related to SLE.

Stress is another commonly reported neuropsychological health issue that intensifies the SLE disease and notably impacts the quality of life of those affected [11]. Stress was found to predict fatigue, depression, and pain among this group, indicating its substantial role in contributing to multiple symptoms [12]. The presence of depression and anxiety and their strong association with stress in SLE patients underscores the urgency for holistic management approaches to address psychological disorders to improve the well-being of individuals navigating this complex autoimmune condition.

Globally, the incidence of SLE ranges from 1.5 to 11 per 100,000 person-years, while the prevalence estimates range from 13 to 7,713.5 per 100,000 individuals [13], as reported in recent reviews representing populations from Asia, Australasia, North and South America, Europe, the UK, and Africa, [1315]. These variations likely reflect differences in ethnicity, study settings, and environment. [13]. Despite this broad range of prevalence and incidence, there exists a significant dearth of comprehensive psychological data, particularly for the Asian and Indian populations.

Furthermore, the lack of linguistically agnostic neuropsychiatric screening tools, digitized health support, scarcity of neuropsychiatric professionals [16], societal stigma surrounding psychological health, socioeconomic constraints, and cultural recognition of such issues collectively compound the challenge and hinder effective monitoring and support for SLE patients in low and middle-income countries (LIMICs) like India. This notable absence raises critical concerns and emphasizes the urgent need for targeted research efforts to address the psychological facets of SLE among the Indian population. Our study aims to assess the psychological well-being of Indian SLE patients using standardized assessments for various psychological domains.

Methods

Participants

G*Power version 3.1.9.6 [17] was used to calculate the minimum sample size required to test the study hypothesis. A F-test, one-way ANOVA (fixed effects, omnibus) was performed for three groups (namely cases, caregivers, and college students), using a medium effect size (0.25) and 80% power to achieve significance (p < 0.05). The sample size calculation indicated that a total of 159 participants (n = 53 for each participant group) would be required to examine the impact of SLE on psychological health and well-being scores. However, the sample size for SLE cases (n = 102) was deliberately increased to enable the use of advanced analyses, such as cluster analysis, to explore the heterogeneity within the SLE group.

In total, 207 participants were recruited for this study using a non-probability sampling method. Of these, 102 participants (F = 92%, age M = 26.84 years, SD = 5.98 years), who fulfilled the 2012 SLE classification criteria [18] were enrolled as cases. The remaining 105 participants served as healthy controls. The healthy control group consisted of two subgroups: (a) the caregiver (CG) group, comprising 52 individuals (F = 54%, age M = 26.60 years, SD = 7.66 years) who were caregivers of SLE patients and had no history of SLE; and (b) the college student (CS) group, which included 53 healthy college students (F = 58%, age M = 21.74 years, SD = 1.85 years) with no personal history of autoimmune diseases.

The specific control groups were chosen to represent individuals from diverse cultural, linguistic, and socioeconomic backgrounds. The CG group was matched to the SLE group on key demographic characteristics, whereas the CS group was matched based on education level only, while differing in their socioeconomic, cultural, and linguistic backgrounds. These differences between the control subgroups allowed us to examine the potential role of demographic factors in psychiatric health reporting compared to SLE cases.

Inclusion criteria required participants to be adults aged between 18 and 45 years and to have completed at least higher secondary education. The upper age limit was chosen to minimize potential confounding effects of midlife factors and related life engagements on cognitive decline [19,20]. A minimum of higher secondary education was a pragmatic choice to ensure that participants could adequately read the instructions and consent form, and to reduce variability associated with education attainment, which is a widely discussed determinant of cognitive test performance [20,21]. The exclusion criteria for the control groups included any personal history of autoimmune diseases or other medical conditions that could affect psychological or cognitive health.

The current study is a part of ongoing research aimed at developing a language-agnostic neuropsychological test battery. The current data may serve as a valuable reference for future standardization efforts involving more diverse populations across varying age and education ranges.

Cases and the caregivers were recruited from the hospital, while college students were recruited from the university campus. Data collection began on 10 May 2023 and concluded on 7 March 2024. Participants did not receive any monetary compensation for their participation.

Procedure

Each session began with an inclusion and exclusion criteria assessment, followed by the consent form. Detailed information about the study and the voluntary nature of participation, including the right to withdraw at any point without repercussions, was provided. Consent form sign-up was a two-step process. First, they were asked to ‘read and sign’ the printed consent form, which briefed them about the study, materials, the associated risks and benefits, the time taken to complete the session, and participants’ right to withdraw at any point in time during the participation. Second, the participants were asked to click on the box to provide their consent to start the session. We included only data from those individuals (i.e., 102 SLE cases and 105 healthy cohorts) who agreed and completed the study. We used the following statement to enable participants to provide their consent after asking for their name and DOB details.

Participants were asked to read the statement saying, “I confirm that I have read and understood the information sheet dated for the above study and have had the opportunity to ask questions. I understand that my participation in the study is voluntary and that I am free to withdraw at any time, without giving any reason, without my medical care or legal rights being affected. I hereby give my consent and give permission for members of the research team to have access to an anonymized version of the data and clinical information related to me to be used for research purposes only. I understand the anonymized data can be shared in the public domain with other researchers worldwide. I understand that my name will not be linked with the research materials, and I will not be identified or identifiable in the report or reports that result from the research. I agree to take part in the above study. I have read the above information and agreed to participate in this study.”

The consent form, instructions, and questionnaires were available in both validated English and Hindi versions, based on the participants’ language preference and convenience. These versions were chosen to ensure that participants fully understood the questions, thereby maintaining the accuracy and reliability of their responses.

Upon obtaining participant consent, the assessment commenced with a detailed demographic and health questionnaire. The psychological well-being questionnaires were randomly assigned to the participants to control the order effect. The experiment was performed in a quiet room, and the session lasted approximately 15–20 minutes. The study received approval from the respective institutional research ethics review board committees (IRB), i.e., Nizam’s Institute of Medical Sciences (NIMS) (No.: EC/NIMS/3037/2022) and International Institute of Information Technology, Hyderabad (IIITH) IRB board (No.: IIITH-IRB-PRO-2023-08 dated 01-01-2023).

Materials and Measures

The assessment comprised five distinct psychological questionnaires, including the Patient Health Questionnaire (PHQ-9) for depression, the Generalized Anxiety Disorder Assessment (GAD-7) for generalized anxiety, the Perceived Stress Scale (PSS-4) for stress, the Spielberger State-Trait Anxiety Inventory (STAI-T) for trait anxiety, and the World Health Organization Quality of Life Brief Assessment (WHOQOL-BREF), collectively aimed to offer a holistic evaluation of SLE related well-being issues.

Patient Health Questionnaire – 9

The PHQ-9 questionnaire was designed as a concise, 9-item self-reported tool to evaluate an individual’s experience of depression within the preceding two weeks, including the assessment date [22]. Each item of the questionnaire examined whether the respondent had been affected by specific problems or symptoms associated with depression during this time frame. Participants were instructed to carefully review each query and rate their experience on a 4-point scale: 0 indicating not at all and 3 signifying nearly every day. The scores for each response were tallied by summing the ratings across all nine items, resulting in a total score that spans a range from 0 to 27. The cut-off scores were 5, 10, 15 and 20 for mild, moderate, moderately severe and severe depression, respectively.

Generalized anxiety disorder – 7

The GAD-7 questionnaire is an effective 7-item, self-reported tool designed to gauge an individual’s generalized anxiety within the preceding two weeks, including the assessment date [23]. Like PHQ-9, GAD also used a similar frequency scale. The scale ranged from 0 = not at all, indicating the absence of the symptom, to 3 = nearly every day, denoting frequent occurrence. Upon completing the assessment, scores for each response were tabulated by summing the ratings across all seven items. This cumulative score represents a comprehensive evaluation of the severity of generalized anxiety experienced by the individual during the specified time frame, spanning a scoring range from 0 to 21. The cut-off scores were 5, 10 and 15 for mild, moderate and severe anxiety levels, respectively.

Perceived stress scale – 4

In this study, we adopted the 4-item variant of PSS-10 due to time constraints and its user-friendly nature [24]. This abbreviated questionnaire aimed to assess the frequency of feelings experienced by participants over the preceding month. Participants were instructed to carefully consider each question and rate their responses on a 5-point scale, ranging from 0 = never to 4 = very often. For evaluation, the scores for the first and fourth questions are directly added, while responses for the second and third questions are reversed on the scale before summation. This method yields a total score ranging from 0 to 16, where higher scores signify elevated levels of perceived stress. A score greater than or equal to 6 was considered the cut-off for high stress.

State-trait anxiety inventory – Trait

STAI is a widely used tool for assessing both state and trait anxiety. This study used a concise version consisting of 5 questions for each state and trait anxiety [25]. In our assessment, we only utilized the segment designed to measure trait anxiety. Trait anxiety refers to the tendency to experience anxiety as a personality characteristic [26]. Unlike generalized anxiety disorder, which is triggered by specific situations and involves distinct structural and functional patterns, trait anxiety is a more constant and pervasive aspect of an individual’s personality [27]. Individuals with trait anxiety show more propensity to experience state anxiety [27]. Participants were instructed to devote sufficient time to contemplate each question and respond based on their general feelings. Participants expressed the extent to which each statement reflected their overall emotional state, using a 4-point scale ranging from 1 = not at all to 4 = very much so. Scores were computed by aggregating the responses across the 5 trait anxiety-related items, resulting in a total score ranging between 5 and 20. A score greater than or equal to 14 was considered the cut-off for high-trait anxiety.

World Health Organization quality of life

The WHOQOL-BREF questionnaire, a shorter version of the original 100-item assessment, was chosen for our study to ensure efficiency and participant convenience. It comprised 26 items incorporating inquiries about the participant’s feelings in the past two weeks, using varying response scales distributed across different domains [28]. Questions prompt individuals to evaluate ‘how much’, ‘how completely’, ‘how often’, ‘how good’, or ‘how satisfied’ they experienced aspects of their life [29]. With items evaluating physical health, psychological well-being, social relationships, and environmental aspects, this abbreviated version offers a more streamlined yet comprehensive assessment of an individual’s quality of life.

Statistical analysis

We used JASP version 0.95.3 [30] to perform the statistical analyses. The chi-squared test was used to analyse the demographics of the three participant groups. Furthermore, we conducted a multivariate analysis to assess the psychological test scores (GAD, PHQ, PSS and STAI-T) as dependent variables across the three participant groups: Cases, CG, and CS.

Box’M test yielded a p = 0.724, suggesting no violation of the multivariate homogeneity of variance. Additionally, multivariate normality was assessed using the Shapiro-Wilk test, adhering to the normalcy assumption (p = 0.052). Further, multicollinearity revealed moderate correlations among the psychological test scores, ranging from ρ=0.295 to ρ=0.646, meeting the assumption criteria. Adhering to the assumptions of homogeneity, multivariate normality, and multicollinearity, MANOVA was employed to analyze the psychological health scores, namely PHQ-9, GAD-7, STAI-T, and PSS-4, across the three participant groups [31].

However, a deviation from normalcy (p < 0.05) was observed for the individual psychological health scores. Consequently, we employed the Kruskal-Wallis test for the post-hoc analysis, followed by Dunn’s test with Bonferroni correction for the pair-wise comparisons. Similarly, the WHOQOL data violated the normalcy assumption and led us to choose the Kruskal-Wallis test to identify specific psychological domains that affected the QOL across three participant groups. Further, Dunn’s post-hoc test with Bonferroni correction was used for pair-wise comparisons.

In addition to the comparative analysis, Spearman’s correlational analysis explored the relationships between psychological health, quality of life, and disease severity. Moreover, we conducted a cluster analysis to identify the heterogeneity within our SLE patient population. We opted for the K-Means algorithm with four psychological test scores as parameters for defining our clusters. Mann-Whitney or chi-squared tests were used to compare the clusters based on the variable types. Finally, we determined the trends of psychological well-being among Indian SLE patients by calculating standard deviations (SD) for each patient’s scores, using the mean and SD of both the health control groups as benchmarks for comparison.

Results

The results section is structured into three main segments. The first segment focuses on the demographics of the participant groups. Secondly, the “Psychological Well-being Score” section compares the psychological health (depression, anxiety and stress) and quality of life scores among the SLE patients and the control groups. Lastly, the “SLE Disease and Psychological Well-being” section delves into the heterogeneity associated with the psychological well-being of SLE patients through correlational and cluster analysis. It explores the relationship between disease severity, psychological health, and quality of life in SLE patients. Additionally, cluster analysis was used to visualize the differences in the distribution of the patient population based on their psychological health scores. Finally, we determine the trends of psychological well-being in our patient population.

Demographics

The analysis focused on categorical demographic variables, including gender, education, occupation, family income, and self-income (Table 1). Cases were demographically matched with the CG group based on education, culture, langauge, and family income. To capture additional diversity, including socioeconomic, cultural, linguistic, and university active life, as factors, we included a second control group comprising college-going young adults (i.e., CS group). The CS group differed from the SLE cases and CG in factors such as on-going college active life and family income, providing additional insights into the impact of these variables on psychological assessment. Notably, a significant proportion of the SLE cases comprised women working as homemakers. Consequently, differences emerged between the Cases and the healthy controls, particularly concerning gender, occupation, and self-income.

Table 1. Demographics of participant groups: Cases (n = 102), CG (n = 52), CS (n = 53). Values are presented as percentage (rounded to whole numbers).

Demographics Cases% CG% CS%
Gender, female 92 54 58
Highest Education
 Secondary 19 10 0
 Higher Secondary 37 38 72
 Tertiary 39 46 24
 Post Graduation 5 6 4
Occupation
 Working 16 39 0
 Non-working 55 17 0
 Students 29 44 100

Among the 102 cases, eighty-eight participants were outpatients and fourteen were inpatients at the time of assessment. The disease activity and damage were assessed using Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus International Collaborating Clinics/ American College of Rheumatology Damage Index (SLICC/ACR-DI), respectively [32,33]. The SLEDAI-2K accounts for organ system involvement and symptoms over the preceding 30 days from the assessment date [32]. Higher SLEDAI-2K scores indicate increased disease activity. The SLEDAI-2K score ranges between 0 and 23 (Mdn = 3), and the SLICC/ACR damage index (SDI) ranges between 0 and 5 (Mdn = 0). Additionally, the BILAG scale was used to assess psychological issues associated with SLE cases [34]. Thirty-three SLE patients were identified as NP+ according to the BILAG scale [34] Clinical Characteristics of the patients are reported in Table 2.

Table 2. Clinical Characteristics of SLE Patients (n = 102). Values are presented as percentage (rounded to whole numbers).

SLE Categories No. of Patients Percentage%
NPSLE (BILAG) 33 32
Acute Cutaneous 63 62
Chronic Cutaneous 21 20
Oral or nasal ulcers 52 51
Non- scarring alopecia 61 60
Arthritis 72 70
Serositis 24 23
Renal 48 47
Neurologic 23 22
Hemolyticanemia 13 13
Leukopenia 65 64
Thrombocytopenia 47 46
ANA 93 91
Anti-dsDNA 63 62
Anti-Sm 23 22
Antiphospholoid antibodies 12 11
Low complement 79 77

Psychological Well-being Score

Psychological health score

Multivariate analysis (MANOVA) revealed a significant difference between the psychological health scores across participant groups (F (2,204) = 2.599; p = 0.009; Wilk’s Λ = 0.904). Kruskal-Wallis was performed separately on the psychological test scores for the three groups of participants. Significant differences were noted in GAD, PSS, and STAI-T scores (Table 3). Dunn’s test with Bonferroni correction in the pair-wise analysis with the GAD and PSS revealed a significantly higher level of anxiety (p = 0.019) and stress (p = 0.019) in SLE patients compared to the caregivers (Fig 1). However, no significant difference was observed with college students (Fig 1). Trait anxiety (STAI-T scores) in SLE patients did not show significant differences with both control groups.

Table 3. Psychological health and WHOQOL scores (Mean and SD), and Kruskal Wallis statistical values for the three groups, Cases, caregivers (CG), and college students (CS). Physical (Phy), Psychological (Psy), Social (Soc), and Environment (Env).

Variables Cases (n = 102) CG (n = 52) CS (n = 53) Kruskal Wallis H(df) Rank ϵ2
PHQ-9 8.15(5.77) 6.78(5.02) 8.50(5.06) 3.22(2) 0.02
GAD-7 8.39(5.25) 5.98(4.47) 7.96(4.53) 7.93(2)* 0.02
PSS-4 7.98(2.68) 6.53(2.56) 7.83(3.28) 7.96(2)* 0.04
STAI-T 11.84(4.13) 10.25(3.66) 10.40(3.49) 7.21(2)* 0.04
WHOQOL Phy 23.70(4.75) 27.87(4.45) 27.91(4.59) 37.46(2)*** 0.18
WHOQOL Psy 18.47(4.68) 22.02(4.54) 21.06(4.68) 20.77(2)*** 0.10
WHOQOL Soc 10.16(2.40) 11.40(2.11) 11.23(2.18) 10.80(2)** 0.05
WHOQOL Env 22.28(5.05) 24.90(5.01) 27.60(4.70) 35.86(2)*** 0.17

Note: * denotes p < 0.05; ** denotes p < 0.01; *** denotes p < 0.001

Fig 1. Raincloud plot depicting scores for (a) Generalized Anxiety Disorder (GAD-7) (b) Perceived Stress Scale (PSS-4) (c) State-Trait Anxiety Inventory – Trait (STAI-T) (d) Patient Health Questionnaire (PHQ-9) for the three groups: Cases, caregivers (CG) and college students (CS).

Fig 1

Note: * denotes p < 0.05; ** denotes p < 0.01; *** denotes p < 0.001.

The raincloud plot (Fig 1) demonstrates the raw distribution of participants across the three groups and helps us visualize the distribution [35] of psychological health issues along with the mean difference between the three groups. The descriptive statistics show that around 40% of cases and college students reported moderate to severe anxiety (GAD score >= 10). However, only 30% caregivers reported a similar experience. Similarly, high trait anxiety (STAI-T score >= 14) was observed in 41% of cases but only 19% of college students and 17% of caregivers. In contrast, high stress (PSS score >= 6) was prevalent in more than 50% of all three participant groups, with 83% of cases, 75% of caregivers, and 73% of college students reported experiencing it in the last month. An almost equal level of depressive state was observed across the groups, with 35% of cases, 28% caregivers and 37% of college students reporting moderate to severe (PHQ score >= 10) depression symptoms.

WHO quality of life score

The results revealed considerable differences in quality of life scores across all domains: physical, psychological, social, and environmental (Table 3). Post-hoc analysis showed significantly lower quality of life scores for SLE patients compared to control groups in the physical, psychological, social and environmental domains (Fig 2). Additionally, college students had significantly better environmental domain scores than caregivers.

Fig 2. Raincloud plot for Quality of Life Scores for (a) physical (b) psychological (c) environmental (d) social for the three groups: Cases, caregivers (CG) and college students (CS).

Fig 2

Note: * denotes p < 0.05; ** denotes p < 0.01; *** denotes p < 0.001.

SLE disease and psychological well-being

Correlational analysis

Spearman’s correlational analysis was conducted to examine the impact of disease severity on the psychological health and quality of life of SLE patients. Disease severity was quantified using SLEDAI-2K (mentioned in the Participants section under Methods). We observed a weak but significant positive correlation of SLEDAI-2K with GAD and PSS scores (Fig 3), suggesting a higher level of stress and anxiety in patients with increased disease severity. Further, the SLEDAI-2K score showed a weak but significant negative correlation with social and environmental domains of quality of life experiences by SLE patients, suggesting poorer social engagement and environmental conditions in patients with increased disease severity.

Fig 3. Spearman’s coefficient (ρ) between psychological health, WHOQOL domains and SLEDAI-2K in SLE Patients.

Fig 3

Note: * denotes p < 0.05; ** denotes p < 0.01; *** denotes p < 0.001.

Further, we examined the relationship between the quality of life scores and the psychological well-being of the patients. There was a consistent negative correlation of all four domains of quality of life (physical, psychological, social and environmental) with the diverse psychological domains (GAD, PHQ, PSS and STAI-T) assessed in our study (Fig 3). A strong and significant negative correlation was observed for the physical domain of QOL with anxiety (GAD) and depression (PHQ). The psychological QOL domain also showed a strong correlation with depression (PHQ), trait anxiety (STAI-T), and generalized anxiety (GAD), indicating the construct validity of these measures.

Cluster analysis

We utilized the K-Means algorithm to identify clusters based on four psychological scores: STAI-T, PHQ-9, GAD-7 and PSS-4. Training parameters included using the ‘Means’ Center type, the Hartigan-Wong algorithm, a maximum of 200 iterations and random sets, feature scaling, and setting the seed to 1. Two clusters were identified with a combined silhouette score of 0.380 (Cluster 1 = 0.410 and Cluster 2 = 0.338). Silhouette scores range from −1 to +1, with higher scores indicating better clustering quality [36]. Fig 4 shows the t-SNE plot for visualizing the cluster memberships [37]. Because of the violation of multivariate homogeneity (p < 0.001) and multivariate normality (p = 0.005) assumptions, we used the non-parametric Mann-Whitney test instead of multivariate analysis (MANOVA) to compare the two clusters. Results revealed that Cluster 2 exhibited poorer psychological health than Cluster 1, evidenced by their higher scores (Table 4) across all psychological tests (Fig 5).

Fig 4. t-SNE plot for clusters. Each coloured dot represents one sample in its respective cluster.

Fig 4

Table 4. Age, psychological health, and WHOQOL scores (Mean and SD) for clusters and effect size (Rank Biserial Correlation of Mann-Whitney test) for comparison between clusters. Physical (Phy), Psychological (Psy), Social (Soc), and Environment (Env).

Variables Cluster 1 (n = 54) Cluster 2 (n = 48) Effect Size
Age 25.29 (6.16) 28.58 (5.33) 0.37**
PHQ-9 4.65 (2.96) 12.10 (5.62) 0.77***
GAD-7 4.24 (2.50) 13.06 (3.18) 0.97***
PSS-4 7.07 (2.61) 9.00 (2.41) 0.41***
STAI-T 9.13 3.0s 14.90 (2.87) 0.81***
WHOQOL Phy 25.50 (4.37) 21.67 (4.36) −0.44***
WHOQOL Psy 20.35 (4.55) 16.35 (3.91) −0.51***
WHOQOL Soc 10.96 (2.21) 9.25 (2.31) −0.41***
WHOQOL Env 23.52 (5.12) 20.90 (4.65) −0.27*

Note: * denotes p < 0.05; ** denotes p < 0.01; *** denotes p < 0.001

Fig 5. Cluster Means for the psychological health scores of the two clusters.

Fig 5

Note: * denotes p < 0.05; ** denotes p < 0.01; *** denotes p < 0.001.

Additionally, Cluster 2 showed lower WHOQOL scores in physical, psychological, social and environmental domains than Cluster 1 (Table 4). Demographically, Cluster 2 differed from Cluster 1 in terms of age (p = 0.001) and occupation (p < 0.001), with Cluster 2 mainly comprising older women who were predominantly unemployed (73% of Cluster 1 was unemployed). Clinically, Clusters 2 and 1 did not differ in the disease severity score (SLEDAI-2K), damage index (SDI), and neuropsychiatric involvement (NPSLE or non-NPSLE based on BILAG scores).

Trends of psychological well-being in Indian SLE patients

We determined the standard deviation (SD) for each patient’s psychological and quality of life scores by comparing them to the mean and standard deviation of two control groups: CG and CS. Our criterion for identifying psychological health deterioration was set at a threshold of greater than 1.5 standard deviations above the mean of the control groups for psychological health scores. Fig 6 illustrates the percentage of SLE patients exhibiting psychological decline in each domain based on this threshold. Compared to CG, 45% of SLE patients displayed symptoms for at least one of the four psychological disorders (depression, generalized anxiety, state anxiety and stress) evaluated in our study. In comparison, when compared to CS, 31% of SLE patients exhibited symptoms for at least one of these disorders.

Fig 6. Percentage of SLE patients with psychological health decline in each domain.

Fig 6

For standard psychological health scores, the criterion was >1.5 SD above the mean of the healthy controls. For the WHOQOL-BREF, it was defined as scores below the mean of healthy controls.

Discussion

The study examines the psychological well-being and quality of life experiences in SLE patients using caregivers and college students as controls. The results revealed elevated levels of stress and anxiety compounded with reduced quality of life (WHOQOL) experiences across all the domains (physical, psychological, social and environmental) in SLE cases compared to the control groups, CG and CS. Additionally, higher disease severity is associated with higher levels of stress and anxiety and poorer quality of social engagement and environment. This elaborated web of correlations suggests that factors contributing to mental health extend beyond psychological factors, incorporating aspects related to physical well-being, social interactions, and the environment. Further, results from cluster analysis highlight the heterogeneity associated with the psychological well-being of SLE patients, revealing distinct distributions within the patient population based on age and employment status. Despite observing a significant relationship between psychological well-being and SLE disease, the pervasive presence of psychological distress symptoms was evident across the groups (Fig 1 and Fig 2) in the current study. The results are discussed in light of previous findings and emerging trends in mental health worldwide and in India.

Psychological Health and SLE

Our study highlights the high prevalence of self-reported psychological health issues in SLE patients, with more than 30% of the cases reporting experiences of depression, anxiety and stress as seen in previous studies [38,39]. Further, the association between disease severity and psychological health aligns with the previous findings and poses a serious concern regarding the cases’ well-being and its association with their daily activities [39].

When compared to their healthy counterparts, SLE patients reported higher levels of anxiety and stress, aligning with previous results [38,40]. However, the current study fails to observe a significant difference between depressive symptoms across cases and healthy controls as seen previously [6]. One explanation could be the widespread nature of psychological health issues among young adults as seen in the raincloud plot. Recent studies [9,10] have raised concern regarding increasing trends of psychological distress among young adults. In India, it is suggested that nearly 15% of the population grapples with mental health issues at least once in their lifetime [9]. The pervasive prevalence and poor recognition of mental health issues among young adults not only weakens the recognition of SLE-induced psychological health concerns among patients but also impedes timely intervention.

Psychological health and quality of life with SLE

Mental health is a complex, multifactorial issue. Among various factors, quality of life significantly correlates with an individual’s mental well-being [41], particularly when someone is grappling with an autoimmune disease. SLE cases’ poorer quality of life experiences across all domains suggest impaired everyday functioning. The compounding effect can be observed with disease severity, notably with the diminished quality of social engagement, an essential requirement for healthy living.

We also observed an association between psychological health and quality of life, suggesting that the better the quality of life is, the better the psychological health will be. By considering factors beyond psychological well-being, such as environmental, social, and physical influences, we gained a more holistic understanding of the overall well-being of SLE patients. The current practices in neuropsychiatric assessment do not focus on the quantitative and qualitative details of the psychological health issues and quality of life of the patients. The current findings recommend the inclusion of a comprehensive neuropsychiatric evaluation of SLE patients as part of regular health care practices at varying levels from primary to tertiary care.

Heterogeneity in psychological Health of SLE patients

Results from the cluster analysis, although moderate (Silhouette score = 0.380), suggest the presence of a distinct pattern in psychological health among the SLE cases. The moderate Silhouette score reflects the complex and interdependent nature of psychological symptoms in SLE cases. These variations were reflected in self-reported scores on depression, generalized anxiety, trait anxiety, and stress levels, with one cluster (i.e., Cluster 2) exhibiting elevated psychological symptoms than the other.

Cluster 2 (n = 48) comprised comparatively older participants (median age = 29 vs. 23 years) with a higher proportion of homemakers, resulting in fewer individuals with formal employment. Specifically, 73% of participants in Cluster 2 were homemakers, 17% were formally employed, and 10% were students, whereas Cluster 1 (n = 54) included 39% homemakers, 15% were formally employed participants, and 46% were students. The older age profile and higher proportion of participants without formal employment in Cluster 2 may help explain the poorer psychological health scores observed in this group compared with the younger, student dominated Cluster 1. These observations resonate with prior studies emphasizing the impact of unemployment on mental health, particularly in regions with limited economic development [42]. Additionally, participants in Cluster 2 reported lower quality of life across physical, psychological, social, and environmental domains, consistent with previous research linking quality of life to the mental health of SLE patients [43].

While these differences may not be directly clinically relevant, they provide insight into the demographic factors contributing to the quality-of-life experiences associated with SLE. These findings are consistent with previous reports highlighting demographic disparities in SLE burden, demonstrating higher incidence and prevalence rates of SLE among Black, Hispanic, and Asian populations compared with White Americans [13]. Overall, these findings highlight the heterogeneous nature of psychosocial well-being among SLE patients and emphasize the importance of considering demographic factors in future research aimed at elucidating the multifaceted contributors to this complexity.

Despite the promising results, a larger sample size would be required to enhance the robustness of the clusters, with multiple clustering methods used to better capture the underlying structure of complex psychological traits.

While psychological health scores on the PHQ-9, GAD-7, and WHO Quality of Life measures showed significant differences between the identified clusters, clinical factors such as disease severity (SLEDAI-2K) and the prevalence of neuropsychiatric manifestations (BILAG scores) did not reveal any significant differences across the identified clusters. This finding was unexpected, especially considering the known association between mental health disorders and central nervous system (CNS) involvement in SLE patients [43]. The lack of association between BILAG scores and psychological health scores may stem from the lack of detailed mental health and quality of life components within BILAG.

These results prompt a critical examination of existing medical protocols for NPSLE classification, which may not fully capture the complexity and nuances of neuropsychiatric conditions lacking factors such as temporal relationships of NPSLE to SLE diagnosis and disease severity as mentioned in previous studies [44]. Therefore, our study suggests the use of a multi-dimensional frequency-based psychological state assessment that enables a more comprehensive outlook of a patient than currently widely used medical protocols.

While current NPSLE medical protocols provide valuable information on the occurrence of neuropsychiatric incidents, they may fall short in offering insights into the frequency, quality, and severity of these occurrences. Therefore, there is a pressing need for an integrated examination that goes beyond binary categorizations and explores the intricate details of the patient experience. To further enrich our understanding, more investigations should delve into the heterogeneity associated with SLE and its nuanced impact on various psychological and quality-of-life domains.

Psychological Health of Indian SLE patients

The trends revealed the presence of at least one psychological symptom in 45% of SLE patients compared to the caregivers. This underscores the substantial presence of psychological symptoms within the patient cohort when compared to the healthy control group matched for age, education, and socio-economic background. These findings are consistent with prior studies in India, which report similar trends in prevalence rates with depression and anxiety being the major symptoms [45,46]. Conversely, when compared against college students as the baseline, only 31% of the patients showed signs of at least one psychological symptom. This highlights the prevalence of mental health issues in young adults [9,47]. Hence, it is important to consider factors such as socioeconomic background and education when defining a healthy control group beyond merely the absence of the disease. Despite an increasing number of studies focusing on the Indian population, there remains a significant gap in well-defined normative baseline data. Future research endeavours are crucial to establish comprehensive baseline data to facilitate more accurate comparisons in this field.

Limitations and Conclusion

Despite the use of cluster analysis to examine the heterogenous nature of psychological health issues within SLE population, we would like to note following caveats:

  1. The current study is limited due to its narrow demographic profiles, particularly in terms education and age. Future studies should involve SLE cases across wide age range and educational backgrounds, as this would help characterize psychological symptoms and their variations among Indian SLE population.

  2. Although the assumptions for MANOVA were met for multivariate analysis, the violation of normality in individual psychological health scores necessitated the use of non-parametric alternatives for post-hoc analyses. While multiple comparison corrections led the use of Bonferroni’s corrections to control Type I error, it increases the risk of Type II errors, potentially reducing the chance to detect subtle effects. Future studies may address these concerns by increasing the sample size and/ or using a longitudinal research design.

  3. Although K-means cluster analysis revealed a significant difference in psychological health and well-being between two clusters based on age and occupation, a larger sample size would be required to asses their clinical significance. Future studies could additionally employ multiple clustering methods along with sensitivity analysis to gain a more comprehensive understanding of the heterogeneity within SLE cases regarding psychological health.

In sum, our study is one of the first studies to provide a comprehensive assessment of the psychological health and quality of life among Indian SLE patients using validated instruments and two sets of healthy controls. Results reveal the presence of anxiety and stress among the SLE patient cohort when compared to their healthy counterparts. We explored the associations between psychological health, quality of life, disease factors and demographic factors. However, given the heterogeneous nature of SLE, a more nuanced analysis of the widespread psychological health issues through approaches like network or regression analysis is needed. Moreover, it’s crucial to acknowledge the diverse spectrum of neuropsychiatric symptoms in SLE, ranging from emotional disorders to significant cognitive impairments. Previous studies have highlighted cognitive deficiencies across various domains critical for daily functioning, emphasizing the importance of investigating SLE’s impact on cognitive health alongside psychological well-being. Incorporating cognitive health assessments will provide a more comprehensive understanding of the intricate relationship between cognitive and psychological health in individuals with SLE.

Data Availability

All data files are available from the Github database (urls: https://github.com/pragya919/Psychological-WellBeing-of-SLE-Patients).

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.D’Cruz DP. Systemic lupus erythematosus. BMJ. 2006;332(7546):890–4. doi: 10.1136/bmj.332.7546.890 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Rahman A, Isenberg DA. Mechanisms of Disease Systemic Lupus Erythematosus. 2008.
  • 3.Sarwar S, Mohamed AS, Rogers S, Sarmast ST, Kataria S, Mohamed KH, et al. Neuropsychiatric Systemic Lupus Erythematosus: A 2021 Update on Diagnosis, Management, and Current Challenges. Cureus. 2021;13(9):e17969. doi: 10.7759/cureus.17969 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Seet D, Allameen NA, Tay SH, Cho J, Mak A. Cognitive Dysfunction in Systemic Lupus Erythematosus: Immunopathology, Clinical Manifestations, Neuroimaging and Management. Rheumatol Ther. 2021;8(2):651–79. doi: 10.1007/s40744-021-00312-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ho RC, Husain SF, Ho CS. Cognitive dysfunction in patients with systemic lupus erythematosus: The challenge in diagnosis and management. Rheumatology Practice and Research. 2018;3. doi: 10.1177/2059902118792434 [DOI] [Google Scholar]
  • 6.Taherzadeh M, Tavakoli M. Comparison of systemic lupus erythematosus patients and healthy individuals in terms of autobiographical memory, mood, and cognitive emotion regulation. Cogn Process. 2021;22(1):131–9. doi: 10.1007/s10339-020-00973-9 [DOI] [PubMed] [Google Scholar]
  • 7.Bai R, Liu S, Zhao Y, Cheng Y, Li S, Lai A, et al. Depressive and Anxiety Disorders in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations. J Immunol Res. 2016;2016:2829018. doi: 10.1155/2016/2829018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kozora E, Ellison MC, Waxmonsky JA, Wamboldt FS, Patterson TL. Major life stress, coping styles, and social support in relation to psychological distress in patients with systemic lupus erythematosus. Lupus. 2005;14(5):363–72. doi: 10.1191/0961203305lu2094oa [DOI] [PubMed] [Google Scholar]
  • 9.Meghrajani VR, Marathe M, Sharma R, Potdukhe A, Wanjari MB, Taksande AB. A Comprehensive Analysis of Mental Health Problems in India and the Role of Mental Asylums. Cureus. 2023;15(7):e42559. doi: 10.7759/cureus.42559 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Heinz A, Liu S. Challenges and chances for mental health care in the 21st century. World Psychiatry. 2022;21(3):423–4. doi: 10.1002/wps.21006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Jolly M, Katz P. Predictors of stress in patients with Lupus. Front Med (Lausanne). 2022;9:986968. doi: 10.3389/fmed.2022.986968 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Azizoddin DR, Jolly M, Arora S, Yelin E, Katz P. Longitudinal Study of Fatigue, Stress, and Depression: Role of Reduction in Stress Toward Improvement in Fatigue. Arthritis Care Res (Hoboken). 2020;72(10):1440–8. doi: 10.1002/acr.24052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, et al. Publisher Correction: Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(10):642. doi: 10.1038/s41584-021-00690-3 [DOI] [PubMed] [Google Scholar]
  • 14.Malaviya AN, Singh RR, Singh YN, Kapoor SK, Kumar A. Prevalence of systemic lupus erythematosus in India. Lupus. 1993;2(2):115–8. doi: 10.1177/096120339300200209 [DOI] [PubMed] [Google Scholar]
  • 15.Tian J, Kang S, Zhang D, Huang Y, Zhao M, Gui X, et al. Global, regional, and national incidence and prevalence of systemic sclerosis. Clin Immunol. 2023;248:109267. doi: 10.1016/j.clim.2023.109267 [DOI] [PubMed] [Google Scholar]
  • 16.Garg K, Kumar CN, Chandra PS. Number of psychiatrists in India: Baby steps forward, but a long way to go. Indian J Psychiatry. 2019;61(1):104–5. doi: 10.4103/psychiatry.IndianJPsychiatry_7_18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kang H. Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 2021;18:17. doi: 10.3352/jeehp.2021.18.17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Petri M, Orbai A-M, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86. doi: 10.1002/art.34473 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Staudinger UM. The positive plasticity of adult development: Potential for the 21st century. Am Psychol. 2020;75(4):540–53. doi: 10.1037/amp0000612 [DOI] [PubMed] [Google Scholar]
  • 20.Hanushek EA, Kinne L, Witthöft F, Woessmann L. Age and cognitive skills: Use it or lose it. Sci Adv. 2025;11(10):eads1560. doi: 10.1126/sciadv.ads1560 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lövdén M, Fratiglioni L, Glymour MM, Lindenberger U, Tucker-Drob EM. Education and cognitive functioning across the life span. Psychological Science in the Public Interest. 2020;21(1):6–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13. doi: 10.1046/j.1525-1497.2001.016009606.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7. doi: 10.1001/archinte.166.10.1092 [DOI] [PubMed] [Google Scholar]
  • 24.Warttig SL, Forshaw MJ, South J, White AK. New, normative, English-sample data for the Short Form Perceived Stress Scale (PSS-4). J Health Psychol. 2013;18(12):1617–28. doi: 10.1177/1359105313508346 [DOI] [PubMed] [Google Scholar]
  • 25.Zsido AN, Teleki SA, Csokasi K, Rozsa S, Bandi SA. Development of the short version of the spielberger state-trait anxiety inventory. Psychiatry Res. 2020;291:113223. doi: 10.1016/j.psychres.2020.113223 [DOI] [PubMed] [Google Scholar]
  • 26.Jouvent R, Bungener C, Morand P, Millet V, Lancrenon S, Ferreri M. Distinction between anxiety state/trait in general practice: a descriptive study. Encephale. 1999;25(1):44–9. [PubMed] [Google Scholar]
  • 27.Saviola F, Pappaianni E, Monti A, Grecucci A, Jovicich J, De Pisapia N. Trait and state anxiety are mapped differently in the human brain. Sci Rep. 2020;10(1):11112. doi: 10.1038/s41598-020-68008-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28(3):551–8. doi: 10.1017/s0033291798006667 [DOI] [PubMed] [Google Scholar]
  • 29.Skevington SM, Lotfy M, O’Connell KA, WHOQOL Group. The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13(2):299–310. doi: 10.1023/B:QURE.0000018486.91360.00 [DOI] [PubMed] [Google Scholar]
  • 30.ASP Team. JASP (Version 0.95.3). 2026.
  • 31.Tabachnick BG, Fidell LS, Ullman JB. Using multivariate statistics. Boston, MA: Pearson. 2013. [Google Scholar]
  • 32.Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–91. [PubMed] [Google Scholar]
  • 33.Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39(3):363–9. doi: 10.1002/art.1780390303 [DOI] [PubMed] [Google Scholar]
  • 34.Yee C-S, Cresswell L, Farewell V, Rahman A, Teh L-S, Griffiths B, et al. Numerical scoring for the BILAG-2004 index. Rheumatology (Oxford). 2010;49(9):1665–9. doi: 10.1093/rheumatology/keq026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Allen M, Poggiali D, Whitaker K, Marshall TR, van Langen J, Kievit RA. Raincloud plots: a multi-platform tool for robust data visualization. Wellcome Open Res. 2021;4:63. doi: 10.12688/wellcomeopenres.15191.2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Rousseeuw PJ. Silhouettes: A graphical aid to the interpretation and validation of cluster analysis. Journal of Computational and Applied Mathematics. 1987;20:53–65. doi: 10.1016/0377-0427(87)90125-7 [DOI] [Google Scholar]
  • 37.Liu H, Yang J, Ye M, James SC, Tang Z, Dong J, et al. Using t-distributed Stochastic Neighbor Embedding (t-SNE) for cluster analysis and spatial zone delineation of groundwater geochemistry data. Journal of Hydrology. 2021;597:126146. doi: 10.1016/j.jhydrol.2021.126146 [DOI] [Google Scholar]
  • 38.Figueiredo-Braga M, Cornaby C, Cortez A, Bernardes M, Terroso G, Figueiredo M, et al. Depression and anxiety in systemic lupus erythematosus: The crosstalk between immunological, clinical, and psychosocial factors. Medicine (Baltimore). 2018;97(28):e11376. doi: 10.1097/MD.0000000000011376 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Shen B, Tan W, Feng G, He Y, Liu J, Chen W, et al. The correlations of disease activity, socioeconomic status, quality of life, and depression/anxiety in Chinese patients with systemic lupus erythematosus. Clin Dev Immunol. 2013;2013:270878. doi: 10.1155/2013/270878 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Peralta-Ramírez MI, Pérez-Mármol JM, Castañeda-Cabestany M, Santos-Ruiz A, Montero-López E, Callejas-Rubio JL. Association between perceived level of stress, clinical characteristics and psychopathological symptoms in women with systemic lupus erythematosus. 2018. [PubMed]
  • 41.Evans S, Banerjee S, Leese M, Huxley P. The impact of mental illness on quality of life: A comparison of severe mental illness, common mental disorder and healthy population samples. Qual Life Res. 2007;16(1):17–29. doi: 10.1007/s11136-006-9002-6 [DOI] [PubMed] [Google Scholar]
  • 42.Paul KI, Moser K. Unemployment impairs mental health: Meta-analyses. Journal of Vocational Behavior. 2009;74(3):264–82. doi: 10.1016/j.jvb.2009.01.001 [DOI] [Google Scholar]
  • 43.Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol. 2014;10(10):579–96. doi: 10.1038/nrneurol.2014.148 [DOI] [PubMed] [Google Scholar]
  • 44.Vivaldo JF, De Amorim JC, Julio PR, De Oliveira RJ, Appenzeller S. Definition of NPSLE: does the ACR nomenclature still hold?. Frontiers in Medicine. 2018;5:138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Abirami V. A study of prevalence of psychosis and other psychiatric disorders and correlation of disease activity with psychiatric disorders in patients with systemic lupus erythematosus: A case control study. Madurai: Madurai Medical College. 2018. [Google Scholar]
  • 46.Grover S, Sahoo S, Naskar C, Sharma A. Psychiatric comorbidities in patients suffering from systemic lupus erythematosus admitted to a tertiary care hospital in Northern India. Lupus. 2023;32(8):1008–18. doi: 10.1177/09612033231177737 [DOI] [PubMed] [Google Scholar]
  • 47.Chadda RK. Youth & mental health: Challenges ahead. 2018. [DOI] [PMC free article] [PubMed]

Decision Letter 0

Aditya Panda

1 Oct 2024

-->PONE-D-24-22554-->-->Psychological well-being of SLE patients: A comprehensive examination of stress, depression, anxiety and quality of life-->-->PLOS ONE

Dear Dr. Srivastava,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 15 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols..

We look forward to receiving your revised manuscript.

Kind regards,

Aditya K. Panda, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

Additional Editor Comments:

Please revise the mansucript as per the comments of the reviewer.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #1: No

**********

-->2. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #1: No

**********

-->3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

**********

-->4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #1: Yes

**********

-->5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #1: Introduction

The introduction sets the stage for the study, providing relevant background on systemic lupus erythematosus (SLE) and its impact on psychological health. It effectively justifies the need for the study by referencing existing literature and highlighting gaps that this research aims to fill.

Methodology

The methodology section is confusing.

1. Participant Selection:

o The study includes SLE patients comprising caregivers (CG) and college students (CS), but is not clear if from 102 participants ( which are 105- line 68- ?????), in the CG group- the subjects have SLE or are just caregivers of the SLE! The authors must write more precisely about how the groups were considered.

o Criteria for inclusion and exclusion:

1. the age smaller than 45 years. Where in the existing literature is the age over 45 linked with cognitive decline? This is a significant limitation of the research. The authors could gather data for all SLE subjects and further consider age-related groups.

2. The criterion “minimum of higher secondary education” has no academic or scientific background to be considered an exclusion criterion. Furthermore, the authors seem to be making significant ethical errors and violating the principle of non-discrimination.

o The registration number from the Ethical Committee is missing!

o In which language were the questionnaires used? Did the authors obtained permission from the principal authors (owners) to use the surveys?

o

2. Measurement Tools

o Psychological assessments: STAI-T, PHQ-9, GAD-7, and PSS-4.

o Quality of Life (QOL) assessments: WHOQOL domains.

o Disease severity: SLEDAI-2K, SDI, and BILAG scores.

o The tools chosen are standard and widely validated, lending credibility to the measurements.

3. Statistical Analysis:

o The authors must revise and reconsider the statements regarding sample size calculation and the number of their study participants. (Lines 177-181). Furthermore, this seems to be an a priori estimation; please provide data for a posteriori sample size. Please also provide the effect sizes. Moreover, it Is not clear which group is the third group – lines 180 and 186.

o Line 188- why consider all cases as a group and perform multivariate analysis? It makes no sense since all data from the CG and CS groups ARE included in the Cases group in the variables measured!

o Lines 230-231- the statement makes no sense.

o Data from tables should be with two decimals.

This is a major methodological error, therefore, in this form, the paper can not be considered for publication.

Furthermore

o However, the combined silhouette score of 0.380 indicates moderate clustering quality. A discussion on this relatively low score and its implications for the robustness of the clusters could strengthen the paper.

o The use of t-SNE for visualization is appropriate, but t-SNE is sensitive to parameter settings. A sensitivity analysis of t-SNE parameters could provide additional validation.

o While K-Means is a popular clustering method, it assumes spherical clusters, which may not always be the case. Exploring alternative clustering methods (e.g., hierarchical clustering or DBSCAN) and comparing results could enhance robustness.

o The reported p-values and correlation coefficients should be consistently formatted. For instance, "p < 0.001" should be uniformly used throughout the paper.

o Provide a more comprehensive discussion on the limitations of clustering methods and statistical analyses used.

o Conduct and report sensitivity analyses for clustering and visualization techniques to ensure robustness of findings.

o Consider alternative clustering methods and compare their results to validate the findings.

o Ensure consistency in reporting statistical results and enhance clarity of figures and tables.

**********

-->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..-->

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.. Please note that Supporting Information files do not need this step.

PLoS One. 2026 May 11;21(5):e0344330. doi: 10.1371/journal.pone.0344330.r002

Author response to Decision Letter 1


19 Oct 2025

Response to Reviewers

On behalf of my co-authors, I would like to sincerely thank the reviewer(s) for their constructive and valuable comments on the various sections of our manuscript. It truly helped in improving the quality of the manuscript. We greatly appreciate reviewer’s time and effort in reviewing our work.

In response to the reviewer’s suggestions, we have prepared this document, as a ‘response to reviewers’, and organized it pointwise. The changes have been incorporated into the main manuscript and are highlighted using track changes for ease of reference. I have also pasted excerpts from the manuscript where required and possible.

Below is a pointwise summary of our responses to the reviewer’s comments:

Reviewer 1:

Question 1: The methodology section is confusing. Below are the questions raised for the methodology section:

a. Participant Selection: The study includes SLE patients comprising caregivers (CG) and college students (CS), but is not clear if from 102 participants ( which are 105- line 68- ?????), in the CG group- the subjects have SLE or are just caregivers of the SLE! The authors must write more precisely about how the groups were considered.

Response: Thank you for highlighting this point. We appreciate the opportunity to clearly describe the group composition in our study. Please refer to the participants section under Methods heading, from line 61-86. The revised content is presented below in italics:

In total, 207 participants were recruited for this study using a non-probabilistic sampling method. Of these, 102 participants (F = 92%, age M = 26.84 years, SD = 5.98 years), who fulfilled the 2012 SLE classification criteria [17] were enrolled as cases. The remaining 105 participants served as healthy controls. The healthy control group consisted of two subgroups: (a) the caregiver (CG) group, comprising 52 individuals (F = 54%, age M = 26.60 years, SD = 7.66 years) who were caregivers of SLE patients and had no history of SLE; and (b) the college student (CS) group, which included 53 healthy college students (F = 58%, age M = 21.74 years, SD= 1.85 years) with no personal history of autoimmune diseases.

The specific control groups were chosen to represent individuals from diverse cultural, linguistic, and socioeconomic backgrounds. The CG group was matched to the SLE group on key demographic characteristics, whereas the CS group was matched based on education level only, while differing in their socioeconomic, cultural, and linguistic backgrounds. These differences between the control subgroups allowed us to examine the potential role of demographic factors in psychiatric health reporting compared to SLE cases.

Regarding SLE cases, out of n=102 cases, eighty-eight outpatients and fourteen admitted SLE cases volunteered for the study. The disease activity and damage were assesses using Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus International Collaborating Clinics/ American College of Rheumatology Damage Index (SLICC/ACR-DI), respectively [18, 19]. The SLEDAI-2K accounts for organ system involvement and symptoms over the preceding 30 days from the assessment date [18]. Higher SLEDAI-2K scores indicate increased disease activity. The SLEDAI-2K score ranges between 0 and 23 (Mdn = 3), and the SLICC/ACR damage index (SDI) ranges between 0 and 5 (Mdn = 0). Additionally, the BILAG scale was used to assess psychological issues associated with SLE cases [20].

b. Criteria for inclusion and exclusion: the questions raised are as follows -

i. the age smaller than 45 years. Where in the existing literature is the age over 45 linked with cognitive decline? This is a significant limitation of the research. The authors could gather data for all SLE subjects and further consider age-related groups.

ii. The criterion “minimum of higher secondary education” has no academic or scientific background to be considered an exclusion criterion. Furthermore, the authors seem to be making significant ethical errors and violating the principle of non-discrimination.

Response: Thank you raising concerns regarding the inclusion/ exclusion criteria. We appreciate your attention to the important issues of inclusivity and diversity and acknowledge that these parameters might appear to be underrepresented in the current study.

However, as this is the first national study that include comprehensive and systematic observations of both psychological and cognitive health (which is excluded from the current draft), our primary aim was to control for potential confounding factors that could influence psychological and cognitive scores. These factors would have required additional adjustments to ensure a fair and valid evaluation.

We agree that future studies will undoubtedly benefit from a broader age and education spectrum by incorporating subgroup analyses to capture the nuances of psychological and cognitive decline across varying education and age ranges.

This limitation has been acknowledged in the discussion section and have now provided more detailed literature support for our decision. We would like to assure the reviewers that the criteria were not intended to be exclusionary, but rather to ensure the methodological rigor during the developmental phase of a novel tool.

Below is the revised paragraph, in italics, from the manuscript. Please refer to lines 87-99.

The inclusion criteria required participants to be adults between 18 and 45 years of age and to have completed at least higher secondary education. The upper age limit was chosen to minimize potential confounding effects of midlife factors and related life engagements on cognitive decline [21, 22]. A minimum of higher secondary education was a pragmatic choice to ensure that participants could adequately read the instructions and consent form, and to reduce variability associated with education attainment, which is a widely discussed determinant of cognitive test performance [22, 23]. The exclusion criteria for the control groups included any personal history of autoimmune diseases or other medical conditions that could affect psychological or cognitive health.

The current study is a part of ongoing research aimed at developing a language-agnostic neuropsychological test battery. The current data may serve as a valuable reference for future standardization efforts involving more diverse populations across varying age and education ranges

c. The registration number from the Ethical Committee is missing!

Response: The registration number from the Ethical Committee has not been provided due to anonymity. We’ve provided the full details. Please refer to the line 136 – 139)

Below are the concerned details:

a. Nizam Institute of Medical Sciences - Review letter No.EC/NIMS/3037/2022

b. International Institute of Information Technology, Hyderabad (IIITH) - IIITH-IRB-PRO-2023-08 dated 01-01-2023.

d. Question: In which language were the questionnaires used? Did the authors obtained permission from the principal authors (owners) to use the surveys?

Response: The questionnaires were administered in both validated English and Hindi versions, depending on the participants' language preference and convenience. These versions were chosen to ensure that the participants fully understood the questions, thereby maintaining the accuracy and reliability of their responses.

Below is the revised content in italics. Please refer to lines 128-131.

The consent form, instructions, and questionnaires were available in both validated English and Hindi versions, based on the participants’ language preference and convenience. These versions were chosen to ensure that participants fully understood the questions, thereby maintaining the accuracy and reliability of their responses.

Question 3: Statistics

a. The authors must revise and reconsider the statements regarding sample size calculation and the number of their study participants. (Lines 177-181). Furthermore, this seems to be an a priori estimation; please provide data for a posteriori sample size. Please also provide the effect sizes. Moreover, it Is not clear which group is the third group – lines 180 and 186.

Response: Thank you for your comment regarding the a priori and posteriori sample size calculation. We would like to clarify that our study used an a priori (prior) sample size calculation, which is standard approach in study design to ensure sufficient statistical power before data collection begins. An a priori sample size is typically recommended to control Type I and Type II errors, while ensuring the study has the necessary power to detect significant effects, if they exist. We used G* Power (version 3.1.9.6) to perform this calculation, and a detailed description is provided in the methods section.

As posteriori sample size calculations are typically used after the study is completed to evaluate the adequacy of the sample size for the observed effect, we are unsure of its relevance in our study. Therefore, we believe that performing a posteriori sample size calculation would not add value in this context.

We hope this response sufficiently addresses the reviewer’s concerns.

Regarding the clarity about the statement, lines 177-181, we have revised the content and move it to the Methods section, under participant sub-section.

Below is the revised paragraph for G* power analysis from the manuscript in italics, which is moved to the Methods section. Please refer to the lines 52 to 60.

G*Power version 3.1.9.6 [31] was used to calculate the minimum sample size required to test the study hypothesis. A F-test, one-way ANOVA (fixed effects, omnibus) was performed for three groups (namely cases, caregivers, and college students), using a medium effect size (0.25) and 80% power to achieve significance (p < 0.05). The sample size calculation indicated that a total of 159 participants (n = 53 for each participant group) would be required to examine the impact of SLE on psychological health and well-being scores. However, the sample size for SLE cases (n = 102) was deliberately increased to enable the use of advanced analyses, such as cluster analysis, to explore the heterogeneity within the SLE group.

To address issues with the line 180-186 – ‘which group is third group’, may have clarity now as we have provided the details in Method section, lines 61-to-69. Please refer to the revised draft in italics, and lines 61-69.

In total, 207 participants were recruited for this study using a non-probabilistic sampling method. Of these, 102 participants (F = 92%, age M = 26.84 years, SD = 5.98 years), who fulfilled the 2012 SLE classification criteria [17] were enrolled as cases. The remaining 105 participants served as healthy controls. The healthy control group consisted of two subgroups: (a) the caregiver (CG) group, comprising 52 individuals (F = 54%, age M = 26.60 years, SD = 7.66 years) who were caregivers of SLE patients and had no history of SLE; and (b) the college student (CS) group, which included 53 healthy college students (F = 58%, age M = 21.74 years, SD= 1.85 years) with no personal history of autoimmune diseases.

b. Line 188 - why consider all cases as a group and perform multivariate analysis? It makes no sense since all data from the CG and CS groups ARE included in the Cases group in the variables measured!

Response: We would like to clarify that the two control groups, i.e., CG and CS, were not part of the SLE cases group. The multivariate analysis of variance (MANOVA) was across the three groups, i.e., cases, CG, and CS, with multiple dependent variables.

c. Lines 230-231- the statement makes no sense.

Response: we revised the statement. Please refer to lines 251-253.

d. Data from tables should be with two decimals.

This is a major methodological error, therefore, in this form, the paper can not be considered for publication.

Response: We revised as per reviewer’s comments. We presented all the percentage scores in round figures, particularly Table 1 and 2. The other tables, representing raw scores or mean values, used two decimal points. For example, Table 3 and 4.

e. Cluster Analyses:

i. However, the combined silhouette score of 0.380 indicates moderate clustering quality. A discussion on this relatively low score and its implications for the robustness of the clusters could strengthen the paper.

Response: Great point! We have revised in the discussion. Please refer to the line no 387-404. Below is the revised section in italics:

Results from cluster analysis, though moderate (Silhouette score = 0.380 ) suggest the presence of distinguishable pattern in psychological health among the SLE cases. The moderate Silhouette score reflects the complex and interdependent nature of psychological symptoms in SLE cases. These variations were reflected in self-reported scores on depression, generalized anxiety, trait anxiety, and stress levels, with one cluster exhibiting elevated psychological symptoms than another.

This cluster was predominantly composed of comparatively older demographic that was largely unemployed. This observation resonates with prior studies emphasizing the impact of unemployment on mental health, particularly in regions with limited economic development [41]. Additionally, individuals in this cluster reported lower quality of life across physical, psychological, social, and environmental domains, aligning with previous research linking quality of life to the mental health of SLE patients [42]. These insights highlight the heterogeneous nature of psychological well-being among SLE patients, emphasizing the role of various demographic factors and advocating for targeted research to uncover the multifaceted contributors to this complexity.

Despite the promising results, a larger sample size would be required to enhance the robustness of the clusters, with multiple clustering methods used to better capture the underlying structure of complex psychological traits.

ii. The use of t-SNE for visualization is appropriate, but t-SNE is sensitive to parameter settings. A sensitivity analysis of t-SNE parameters could provide additional validation. Conduct and report sensitivity analyses for clustering and visualizations techniques to ensure robustness of findings.

Response: Thank you for your insightful comment. To address the concern raised, we performed multiple iterations of K-means cluster analysis with varying maximum iterations along with random sets ranging from 25-400 in JASP version 0.95.3. These iterations yielded stable Silhouette scores (0.38) suggesting that the clustering pattern was robust and stable.

We acknowledge that t-SNE is sensitive to parameter settings, and formal sensitivity analysis could provide additional insights. However, due to time and resource constraints, we were unable to conduct this analysis for the current manuscript.

iii. While K-Means is a popular clustering method, it assumes spherical clusters, which may not always be the case. Exploring alternative clustering methods (e.g., hierarchical clustering or DBSCAN) and comparing results could enhance robustness.

Response: Thank you for your valuable comment. While K-Means clustering assumes spherical cluster structures, it remains a widely used and interpretable method, particularly suited for exploratory analysis of continuous psychological data such as STAI-T, PHQ-9, GAD-7, and PSS-4 scores [1]. Given the exploratory nature of this study, K-Means provided a practical and effective approach for identifying broad psychological patterns in the SLE patient population.

The number of clusters was determined based on a combination of silhouette analysis and interpretability of results, ensuring that the identified groups had both statistical and clinical relevance. We acknowledge that psychological symptoms may not strictly conform to spherical distributions, and future studies could employ alternative clustering algorithms (e.g., hierarchical clustering, DBSCAN) to validate and potentially refine these findings. Additionally, the current study was not methodologically focused on comparing the robustness of different clustering methods, and future research could e

Attachment

Submitted filename: Response to Reviewers_PS_18.10.2025.pdf

pone.0344330.s002.pdf (160KB, pdf)

Decision Letter 1

Aditya Panda

20 Nov 2025

<div>PONE-D-24-22554R1-->-->Psychological well-being of SLE patients: A comprehensive examination of stress, depression, anxiety and quality of life-->-->PLOS ONE

Dear Dr. Srivastava,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Revise your MS in accordance with the reviewers' suggestionsRevise your MS in accordance with the reviewers' suggestions.

==============================

Please submit your revised manuscript by Jan 04 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:-->

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

-->If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols..

We look forward to receiving your revised manuscript.

Kind regards,

Aditya K. Panda, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Reviewers' comments are favourable; however, authors must revise their manuscript as per the suggestions.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

-->Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.-->

Reviewer #2: (No Response)

Reviewer #3: All comments have been addressed

**********

-->2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. -->

Reviewer #2: Yes

Reviewer #3: Yes

**********

-->3. Has the statistical analysis been performed appropriately and rigorously? -->

Reviewer #2: Yes

Reviewer #3: I Don't Know

**********

-->4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #2: Yes

Reviewer #3: Yes

**********

-->5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.-->

Reviewer #2: Yes

Reviewer #3: Yes

**********

-->6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)-->

Reviewer #2: Overall, the study seems to have been conducted sincerely. Language seems to have been improved significantly compared to the previous version.

Please find detailed comments.

Comment 1

Please reframe the following sentences (they seem incomplete)

Abstract - Results indicate the prevalence of stress and generalized and trait anxiety among the SLE patients, except for depression. (Please mention whether prevalence is high or low)

Page 2,Line 22 - When compared with rheumatoid arthritis (another autoimmune disease) and without autoimmune conditions, SLE patients reported higher distress than others

Comment 2

In the introduction, the authors describe the prevalence of SLE as 3.2 - 3000/100,000 individuals. The reference quoted does not give such a high prevalence. Please correct it.

Comment 3

Second paragraph of the Methods section on Page 2 describing participant details should be part of the Results section.

Comment 4

The statement from the consent form can be included as part of the annexure and does not need to be a part of the main manuscript (Procedure)

Comment 5

The cluster differences highlighted in the discussion are not sufficiently wide between the two groups to yield any clinical utility. The age difference between the two groups is only 3 years (25 in Cluster 1 and 28 in Cluster 2). Technically, both clusters are young.

Similarly, with regard to occupation, unemployment rates were abnormally high in both clusters (73% in the lower cluster). Please mention the unemployment rates in both clusters. Also, the difference may be statistically significant, but it does not appear to be clinically meaningful.

Please discuss this in the limitations in the discussion on cluster analysis. This could be due to a small sample size.

Reviewer #3: If possible please address the relation between neuropsychiatric SLE ,your results and any available related markers ,also as regards anexity family members and caregiver inclusion in the study will add much to the objectivity of the results

**********

-->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..-->

Reviewer #2: No

Reviewer #3: Yes: Seham Abdallah ElazabSeham Abdallah Elazab

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

-->

PLoS One. 2026 May 11;21(5):e0344330. doi: 10.1371/journal.pone.0344330.r004

Author response to Decision Letter 2


7 Feb 2026

Response to Reviewers

On behalf of my co-authors, I would like to sincerely thank the reviewer(s) for their constructive and valuable comments on the various sections of our manuscript. It truly helped in improving the quality of the manuscript. We greatly appreciate reviewer’s time and effort in reviewing our work.

In response to the reviewer’s suggestions, we have prepared this document, as a ‘response to reviewers’, and organized it pointwise. The changes have been incorporated into the main manuscript and are highlighted using track changes for ease of reference. I have also pasted excerpts from the manuscript where required and possible.

Below is a pointwise summary of our responses to the reviewer’s comments:

Reviewer 2:

Comment 1: Point 1: Results indicate the prevalence of stress and generalized and trait anxiety among the SLE patients, except for depression. (Please mention whether prevalence is high or low)

Response: Thank you for highlighting this. The text has been revised. The revised content is presented below in italics:

“Results indicate a high prevalence of stress, depression, and both generalized and trait anxiety among the SLE patients”.

Point 2: Page 2,Line 22 - When compared with rheumatoid arthritis (another autoimmune disease) and without autoimmune conditions, SLE patients reported higher distress than others.

Response: The text has been revised. Please refer to the lines, 22 -23 in the manuscript without track-changes.

Comment 2: In the introduction, the authors describe the prevalence of SLE as 3.2 - 3000/100,000 individuals. The reference quoted does not give such a high prevalence. Please correct it.

Response: The prevalence figures have been revised. We’ve also added a recent reference to highlight the wide range of reported incidence and prevalence. Please refer to the lines 36 -40 in the revised manuscript.

Comment 3: Second paragraph of the Methods section on Page 2 describing participant details should be part of the Results section

Response: This has been revised. Please refer to the lines, 249-259.

Comment 4: The statement from the consent form can be included as part of the annexure and does not need to be a part of the main manuscript (Procedure)

Response: We have chosen to retain this section in the manuscript to highlight the best practices in participant consent.

Comment 5: The cluster differences highlighted in the discussion are not sufficiently wide between the two groups to yield any clinical utility. The age difference between the two groups is only 3 years (25 in Cluster 1 and 28 in Cluster 2). Technically, both clusters are young. Similarly, with regard to occupation, unemployment rates were abnormally high in both clusters (73% in the lower cluster). Please mention the unemployment rates in both clusters. Also, the difference may be statistically significant, but it does not appear to be clinically meaningful. Please discuss this in the limitations in the discussion on cluster analysis. This could be due to a small sample size.

Response: Thank you once again for these valuable suggestions. The discussion section has been revised. Please refer to the revised sections from line, 397-420 in the revised manuscript. Below the revised text in italics:

Cluster 2 (n = 48) comprised comparatively older participants (median age = 29 vs. 23 years) with a higher proportion of homemakers, resulting in fewer individuals with formal employment. Specifically, 73% of participants in Cluster 2 were homemakers, 17% were formally employed, and 10% were students, whereas Cluster 1 (n = 54) included 39% homemakers, 15% were formally employed participants, and 46% were students. The older age profile and higher proportion of participants without formal employment in Cluster 2 may help explain the poorer psychological health scores observed in this group compared with the younger, student dominated Cluster 1. These observations resonate with prior studies emphasizing the impact of unemployment on mental health, particularly in regions with limited economic development [42]. Additionally, participants in Cluster 2 reported lower quality of life across physical, psychological, social, and environmental domains, consistent with previous research linking quality of life to the mental health of SLE patients [43].

While these differences may not be directly clinically relevant, they provide insight into the demographic factors contributing to the quality-of-life experiences associated with SLE. These findings are consistent with previous reports highlighting demographic disparities in SLE burden, demonstrating higher incidence and prevalence rates of SLE among Black, Hispanic, and Asian populations compared with White Americans [13]. Overall, these findings highlight the heterogeneous nature of psychosocial well-being among SLE patients and emphasize the importance of considering demographic factors in future research aimed at elucidating the multifaceted contributors to this complexity.

Despite the promising results, a larger sample size would be required to enhance the robustness of the clusters, with multiple clustering methods used to better capture the underlying structure of complex psychological traits.

Reviewer 2: If possible please address the relation between neuropsychiatric SLE ,your results and any available related markers ,also as regards anxiety family members and caregiver inclusion in the study will add much to the objectivity of the results.

Response: Thank you for this suggestion. The current study included only the PHQ, GAD, STAI-T, WHO Brief, and BILAG assessments. However, your recommendations regarding additional markers, and familial history are highly valuable, and we will consider them in our future research and analyses.

Attachment

Submitted filename: Response to Reviewers_Rebuttle V2.doc

pone.0344330.s003.doc (40KB, doc)

Decision Letter 2

Aditya Panda

18 Feb 2026

Psychological well-being of SLE patients: A comprehensive examination of stress, depression, anxiety and quality of life

PONE-D-24-22554R2

Dear Dr. Srivastava,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support..

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Aditya K. Panda, Ph.D.

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Aditya Panda

PONE-D-24-22554R2

PLOS One

Dear Dr. Srivastava,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Aditya K. Panda

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers_PS_18.10.2025.pdf

    pone.0344330.s002.pdf (160KB, pdf)
    Attachment

    Submitted filename: Response to Reviewers_Rebuttle V2.doc

    pone.0344330.s003.doc (40KB, doc)

    Data Availability Statement

    All data files are available from the Github database (urls: https://github.com/pragya919/Psychological-WellBeing-of-SLE-Patients).


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES